|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...4041424344454647484950...110111» |
- New trial: Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=40, Recruiting, Sponsor: Revalesio Corporation
- New trial: AMPAMAVIR: Prevalence of HPV Transmission During Medically Assisted Procreation Procedures (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=915, Recruiting, Sponsor: Centre Hospitalier Universitaire de Saint Etienne
- ||| trebananib (AMG 386) / Amgen
Trial completion, Combination therapy, Metastases: AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR (clinicaltrials.gov) - Aug 14, 2015
P1, N=103, Completed, Sponsor: Amgen
Active, not recruiting --> Completed
- Elonva (corifollitropin alfa) / Organon
Trial primary completion date: COMPORT: Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial (clinicaltrials.gov) - Aug 14, 2015
P3, N=150, Recruiting, Sponsor: Universitair Ziekenhuis Brussel
Active, not recruiting --> Completed Trial primary completion date: Mar 2015 --> Jan 2016
- Trial primary completion date, HEOR: Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=28, Active, not recruiting, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Trial primary completion date: Mar 2015 --> Jan 2016 Trial primary completion date: Sep 2015 --> Feb 2016
- || Trial primary completion date: Combining LHu With Ultrasound Monitoring in IUI (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=500, Recruiting, Sponsor: OVO R & D
Trial primary completion date: Sep 2015 --> Feb 2016 Trial primary completion date: Jan 2015 --> Jan 2016
- Trial primary completion date: Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=150, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Jan 2015 --> Jan 2016 Trial primary completion date: Feb 2016 --> Feb 2017
- Trial initiation date: SeTPAT: Treponema Pallidum-specific Proteomic Changes in Patients With Incident Syphilis Infection (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=150, Recruiting, Sponsor: Institute of Tropical Medicine, Belgium
Trial primary completion date: Feb 2016 --> Feb 2017 Initiation date: Jan 2014 --> Jul 2014
- Avastin (bevacizumab) / Roche
Trial primary completion date, Metastases: Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma (clinicaltrials.gov) - Aug 13, 2015
P2, N=38, Active, not recruiting, Sponsor: David O'Malley
Initiation date: Jan 2014 --> Jul 2014 Trial primary completion date: Aug 2012 --> Nov 2016
- Trial initiation date: Accuracy of Portable Colposcopy and HPV Genotypes Among HIV+ Women (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=500, Not yet recruiting, Sponsor: Duke University
Trial primary completion date: Aug 2012 --> Nov 2016 Initiation date: Feb 2015 --> Aug 2015
- |||| opigolix (ASP1707) / Astellas
Trial completion: A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain (clinicaltrials.gov) - Aug 13, 2015
P2, N=912, Completed, Sponsor: Astellas Pharma Europe B.V.
Initiation date: Feb 2015 --> Aug 2015 Active, not recruiting --> Completed
- Biomarker, Enrollment change: Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=20, Terminated, Sponsor: Dick Domanik
Active, not recruiting --> Completed N=320 --> 20
- New trial: p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=100, Active, not recruiting, Sponsor: Parc de Salut Mar
- Trial completion: Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study) (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=699, Completed, Sponsor: Centers for Disease Control and Prevention
N=320 --> 20 Active, not recruiting --> Completed
- | carboplatin / Generic mfg., cisplatin / Generic mfg.
Trial completion, Trial primary completion date, Surgery, Metastases: Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Aug 13, 2015
P3, N=704, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jan 2014 --> Jan 2009
- ||||| Enrollment change, Trial initiation date, Trial primary completion date: BASIC (Boric Acid, Alternate Solution for Intravaginal Colonization) Study (clinicaltrials.gov) - Aug 13, 2015
P2/3, N=240, Recruiting, Sponsor: University of British Columbia
Active, not recruiting --> Completed | Trial primary completion date: Jan 2014 --> Jan 2009 N=120 --> 240 | Initiation date: Oct 2008 --> Apr 2014 | Trial primary completion date: Dec 2015 --> Dec 2016
- Trial completion, Trial primary completion date: Bacterial Vaginosis Screening at IUD Insertion (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=70, Completed, Sponsor: St. Michael's Hospital, Toronto
N=120 --> 240 | Initiation date: Oct 2008 --> Apr 2014 | Trial primary completion date: Dec 2015 --> Dec 2016 Active, not recruiting --> Completed | Trial primary completion date: Mar 2012 --> Mar 2009
- Trial completion: BSARTA: Behavioral Science Aspects of Rapid Test Acceptance (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=1200, Completed, Sponsor: California State University, Long Beach
Active, not recruiting --> Completed | Trial primary completion date: Mar 2012 --> Mar 2009 Recruiting --> Completed
- Enrollment change, Trial withdrawal: Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol (clinicaltrials.gov) - Aug 12, 2015
P3, N=0, Withdrawn, Sponsor: Eurofarma Laboratorios S.A.
Recruiting --> Completed N=656 --> 0 | Not yet recruiting --> Withdrawn
- Enrollment change, Trial withdrawal: Evaluation of the Performance of Chembio's DPP(R) Syphilis Screen & Confirm Rapid Test System (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=0, Withdrawn, Sponsor: Chembio Diagnostic Systems, Inc.
N=656 --> 0 | Not yet recruiting --> Withdrawn N=915 --> 0 | Suspended --> Withdrawn
- metformin / Generic mfg., clomifene citrate / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date: Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin (clinicaltrials.gov) - Aug 12, 2015
P3, N=0, Withdrawn, Sponsor: OVO R & D
N=915 --> 0 | Suspended --> Withdrawn N=401 --> 0 | Suspended --> Withdrawn | Trial primary completion date: May 2015 --> Nov 2013
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
Trial completion, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - Aug 12, 2015
P1, N=12, Completed, Sponsor: Case Comprehensive Cancer Center
N=401 --> 0 | Suspended --> Withdrawn | Trial primary completion date: May 2015 --> Nov 2013 Active, not recruiting --> Completed
- ||| Trial completion, Trial primary completion date: Patient Reported Symptoms in Ovarian Cancer (PRECISION) (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=56, Completed, Sponsor: Genentech, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Apr 2015
- Enrollment change, Trial withdrawal, Trial primary completion date: Utility of Fallopian Tube Cocultures in Assisted Reproductive Technology (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=0, Withdrawn, Sponsor: Weill Medical College of Cornell University
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Apr 2015 N=15 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2017 --> Aug 2015
- Enrollment open, Trial initiation date: Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=150, Recruiting, Sponsor: Duke University
N=15 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2017 --> Aug 2015 Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Aug 2015
- ||| Trial completion, Preclinical: Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=100, Completed, Sponsor: OVO R & D
Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Aug 2015 Recruiting --> Completed
- Enrollment change, Trial termination, Trial primary completion date: Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF (clinicaltrials.gov) - Aug 11, 2015
P2/3, N=17, Terminated, Sponsor: National and Kapodistrian University of Athens
N=70 --> 17 | Recruiting --> Terminated | Trial primary completion date: Feb 2014 --> Jan 2015; Obtained results were not good. Protocol was proved ineffective.
- Enrollment open, Enrollment change, Trial primary completion date: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Aug 11, 2015
P2, N=100, Recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Protocol was proved ineffective. Active, not recruiting --> Recruiting | N=60 --> 100 | Trial primary completion date: Sep 2015 --> Aug 2016
- ||||| Orilissa (elagolix) / AbbVie
Enrollment closed: A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain (clinicaltrials.gov) - Aug 11, 2015
P3, N=788, Active, not recruiting, Sponsor: AbbVie
Active, not recruiting --> Recruiting | N=60 --> 100 | Trial primary completion date: Sep 2015 --> Aug 2016 Recruiting --> Active, not recruiting
- Trial completion: Vitamin D Deficiency and Pregnancy Rates in Women Undergoing Frozen Embryo Transfer (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=280, Completed, Sponsor: Universitair Ziekenhuis Brussel
Recruiting --> Active, not recruiting Recruiting --> Completed
- | cabergoline / Generic mfg.
Trial completion: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Aug 11, 2015
P3, N=300, Completed, Sponsor: Cairo University
Recruiting --> Completed Active, not recruiting --> Completed
- Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Enrollment change, Trial termination, Trial primary completion date: Tivozanib As Maintenance Therapy In GYN (clinicaltrials.gov) - Aug 11, 2015
P2, N=4, Terminated, Sponsor: Dana-Farber Cancer Institute
Active, not recruiting --> Completed N=60 --> 4 | Recruiting --> Terminated | Trial primary completion date: Mar 2016 --> Jul 2015; due to slow accrual
- Enrollment closed, Trial primary completion date: Ensuring Communication in Hospice by Oncology Study (ECHO) (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: Massachusetts General Hospital
N=60 --> 4 | Recruiting --> Terminated | Trial primary completion date: Mar 2016 --> Jul 2015; due to slow accrual Recruiting --> Active, not recruiting | Trial primary completion date: May 2017 --> Dec 2015
- | 7-Hydroxystaurosporine (UCN-01) / National Cancer Institute
Trial completion, Combination therapy, Metastases: UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Aug 9, 2015
P2, N=0, Completed, Sponsor: University Health Network, Toronto
Recruiting --> Active, not recruiting | Trial primary completion date: May 2017 --> Dec 2015 Suspended --> Completed
- ||| New trial, Head-to-Head: A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China (clinicaltrials.gov) - Aug 6, 2015
P=N/A, N=372, Not yet recruiting, Sponsor: University of North Carolina, Chapel Hill
- ||| Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Dilapan-S Osmotic Dilator in Pre-induction of Labor (clinicaltrials.gov) - Aug 6, 2015
P=N/A, N=125, Completed, Sponsor: Medicem International CR s.r.o.
Suspended --> Completed Not yet recruiting --> Completed | N=80 --> 125 | Initiation date: Mar 2014 --> May 2013 | Trial primary completion date: Jul 2014 --> Oct 2013
- New trial: Effectiveness of Single Step Culture Media and Sequential Culture Media on Blastulation Rate (clinicaltrials.gov) - Aug 5, 2015
P=N/A, N=448, Not yet recruiting, Sponsor: Vietnam National University
- | Vagifem (estradiol) / Novo Nordisk
New P4 trial: The Vaginal Health Trial (clinicaltrials.gov) - Aug 5, 2015
P4, N=300, Not yet recruiting, Sponsor: Fred Hutchinson Cancer Research Center
- |||||||||| New P3 trial: PRISM: Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis (clinicaltrials.gov) - Aug 5, 2015
P3, N=650, Not yet recruiting, Sponsor: Laboratoire Innotech International
- Vistide (cidofovir) / Gilead
New P1 trial: HPV-RX: Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers (clinicaltrials.gov) - Aug 5, 2015
P1, N=15, Completed, Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
- New trial, Biopsy: Fischer Cone Biopsy Excisor Versus Loop Excision Procedure for Conization (clinicaltrials.gov) - Aug 4, 2015
P=N/A, N=160, Recruiting, Sponsor: Zydolab - Institute of Cytology and Immune Cytochemistry
- ||||| HSV vaccine (GEN-003) / Genocea, Shionogi
New P2 trial: Evaluating New Formulation of Therapeutic HSV-2 Vaccine (clinicaltrials.gov) - Aug 4, 2015
P2, N=90, Not yet recruiting, Sponsor: Genocea Biosciences, Inc.
- New trial: mesosalpinx: Case Report of Endometrioma in Layers of Broad Ligament. (clinicaltrials.gov) - Aug 3, 2015
P=N/A, N=1, Completed, Sponsor: Ruby Hall IVF and Endoscopy Centre
- letrozole / Generic mfg., clomifene citrate / Generic mfg.
Trial completion: Ovulation Induction in Clomiphene Citrate Resistant PCO Women (clinicaltrials.gov) - Aug 1, 2015
P0, N=100, Completed, Sponsor: Cairo University
Not yet recruiting --> Completed | N=80 --> 125 | Initiation date: Mar 2014 --> May 2013 | Trial primary completion date: Jul 2014 --> Oct 2013 Recruiting --> Completed
- Enrollment open, Trial initiation date, Trial primary completion date, HEOR: Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers (clinicaltrials.gov) - Aug 1, 2015
P=N/A, N=30, Recruiting, Sponsor: City of Hope Medical Center
Recruiting --> Completed Not yet recruiting --> Recruiting | Initiation date: Dec 2015 --> Jul 2015 | Trial primary completion date: Dec 2017 --> Jul 2017
- New trial: Understanding the Value of Community Vital Signs in Primary Care (clinicaltrials.gov) - Jul 31, 2015
P=N/A, N=170000, Not yet recruiting, Sponsor: Virginia Commonwealth University
- New trial: SHS: Improvement of STI Detection in Adolescent Emergency Department Patients (clinicaltrials.gov) - Jul 28, 2015
P=N/A, N=800, Recruiting, Sponsor: Children's Research Institute
- | New P2 trial: A Trial of Comparing the Pathology Status of Lymphoseek (clinicaltrials.gov) - Jul 28, 2015
P2, N=40, Not yet recruiting, Sponsor: Navidea Biopharmaceuticals
- Enrollment open, Metastases: TIL Therapy for Metastatic Ovarian Cancer (clinicaltrials.gov) - Jul 24, 2015
P1, N=6, Recruiting, Sponsor: Inge Marie Svane
Not yet recruiting --> Recruiting | Initiation date: Dec 2015 --> Jul 2015 | Trial primary completion date: Dec 2017 --> Jul 2017 Not yet recruiting --> Recruiting
- Enrollment status: 3DRCT: Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? (clinicaltrials.gov) - Jul 22, 2015
P1, N=42, Enrolling by invitation, Sponsor: Brigham and Women's Hospital
Not yet recruiting --> Recruiting Recruiting --> Enrolling by invitation